Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exemestane and Celecoxib as Neoadjuvant Treatment in Breast Cancer
NCT00201773Phase 2Completed
- Sponsor
- The Ohio State University Comprehensive Cancer Center – James Cancer Hospital
- Start
- Jul 2003
- Primary completion
- Nov 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of celecoxib oral solution in breast cancer, sponsored by The Ohio State University Comprehensive Cancer Center – James Cancer Hospital. Started Jul 2003; status: completed.
02
Drugs
celecoxib oral solution
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00201773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00201773.